MT, R., JA, M., JJ, R., JW, B., K, B., CJ, M., . . . NJ, L. (2012). Development of potent macrocyclic inhibitors of genotype 3a HCV NS3/4A protease. Bioorganic & medicinal chemistry letters, 22(23), 7201. https://doi.org/10.1016/j.bmcl.2012.08.106
Chicago Style (17th ed.) CitationMT, Rudd, et al. "Development of Potent Macrocyclic Inhibitors of Genotype 3a HCV NS3/4A Protease." Bioorganic & Medicinal Chemistry Letters 22, no. 23 (2012): 7201. https://doi.org/10.1016/j.bmcl.2012.08.106.
MLA (9th ed.) CitationMT, Rudd, et al. "Development of Potent Macrocyclic Inhibitors of Genotype 3a HCV NS3/4A Protease." Bioorganic & Medicinal Chemistry Letters, vol. 22, no. 23, 2012, p. 7201, https://doi.org/10.1016/j.bmcl.2012.08.106.
Warning: These citations may not always be 100% accurate.